Oncology Oncologists' Perspectives on Recent Developments in Advanced Breast Cancer: Promising Progress with Curative Intent Just Out of Reach Recent developments across three subtypes of advanced breast cancer – HER2+, TNBC, and HR+/HER2- have generated enthusiasm among oncologists in the United States. While oncologists are stopping short of calling advanced breast cancer
